🚀 VC round data is live in beta, check it out!
BactiQuant Valuation Multiples
Discover revenue and EBITDA valuation multiples for BactiQuant and similar public comparables like GEL, Norditek Group, Orege, Ocean GeoLoop and more.
BactiQuant Overview
About BactiQuant
BactiQuant AS focuses on delivering technology that ensures optimum usage and handling of water around the world. The company's activities include the development, production, sale and service of BactiQuant Online and BactiQuant Mobile Lab with associated test kits/substrate for the quantification and detection of bacteria in water. Its segments are Aquaculture, Data Centres, Oil & Gas, Water Utility, Industry, and Pharma. The group's products are BQ Online 2.0 PRO, BQ Online, BQ Mobile Lab, and Analysis Kits.
Founded
1999
HQ
Employees
12
Website
Financials (FY)
EV
$14M
BactiQuant Financials
BactiQuant reported last fiscal year revenue of $1M and negative EBITDA of ($2M).
In the same fiscal year, BactiQuant generated ($342K) in gross profit, ($2M) in EBITDA losses, and had net loss of ($2M).
BactiQuant P&L
In the most recent fiscal year, BactiQuant reported revenue of $1M and EBITDA of ($2M).
BactiQuant expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $1M | XXX | XXX | XXX |
| Gross Profit | — | XXX | ($342K) | XXX | XXX | XXX |
| Gross Margin | — | XXX | (26%) | XXX | XXX | XXX |
| EBITDA | — | XXX | ($2M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (125%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (150%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($2M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (166%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
BactiQuant Stock Performance
BactiQuant has current market cap of $16M, and enterprise value of $14M.
Market Cap Evolution
BactiQuant's stock price is $0.42.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $14M | $16M | -0.6% | XXX | XXX | XXX | $-0.06 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialBactiQuant Valuation Multiples
BactiQuant trades at 11.0x EV/Revenue multiple, and (8.8x) EV/EBITDA.
BactiQuant Financial Valuation Multiples
As of April 11, 2026, BactiQuant has market cap of $16M and EV of $14M.
Equity research analysts estimate BactiQuant's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
BactiQuant has a P/E ratio of (7.3x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $16M | XXX | $16M | XXX | XXX | XXX |
| EV (current) | $14M | XXX | $14M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 11.0x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (8.8x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (7.3x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | (41.7x) | XXX | XXX | XXX |
| P/E | — | XXX | (7.3x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (8.7x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified BactiQuant Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
BactiQuant Margins & Growth Rates
BactiQuant's revenue in the last fiscal year grew by 16%.
BactiQuant's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
BactiQuant Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 16% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (125%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 1% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 124% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
BactiQuant Public Comps
See public comps and valuation multiples for other Waste & Environmental Services comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| GEL | XXX | XXX | XXX | XXX | XXX | XXX |
| Norditek Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Orege | XXX | XXX | XXX | XXX | XXX | XXX |
| Ocean GeoLoop | XXX | XXX | XXX | XXX | XXX | XXX |
| Bioextrax | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
BactiQuant M&A Activity
BactiQuant acquired XXX companies to date.
Last acquisition by BactiQuant was on XXXXXXXX, XXXXX. BactiQuant acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by BactiQuant
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialBactiQuant Investment Activity
BactiQuant invested in XXX companies to date.
BactiQuant made its latest investment on XXXXXXXX, XXXXX. BactiQuant invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by BactiQuant
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout BactiQuant
| When was BactiQuant founded? | BactiQuant was founded in 1999. |
| Where is BactiQuant headquartered? | BactiQuant is headquartered in Denmark. |
| How many employees does BactiQuant have? | As of today, BactiQuant has over 12 employees. |
| Is BactiQuant publicly listed? | Yes, BactiQuant is a public company listed on Nasdaq Copenhagen. |
| What is the stock symbol of BactiQuant? | BactiQuant trades under BACTIQ ticker. |
| When did BactiQuant go public? | BactiQuant went public in 2021. |
| Who are competitors of BactiQuant? | BactiQuant main competitors are GEL, Norditek Group, Orege, Ocean GeoLoop. |
| What is the current market cap of BactiQuant? | BactiQuant's current market cap is $16M. |
| What is the current revenue of BactiQuant? | BactiQuant's last fiscal year revenue is $1M. |
| What is the current EV/Revenue multiple of BactiQuant? | Current revenue multiple of BactiQuant is 11.0x. |
| Is BactiQuant profitable? | No, BactiQuant is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.